ArticleDrug design, development and therapy2026

Preclinical Pharmacokinetics, ADME, and Drug-Drug Interaction Evaluation of S024, a Novel p38/MK2 Inhibitor for Rheumatoid Arthritis.

Qianlei Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.